JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion

被引：0
|
作者：
Wing-Yan Au
Thomas S. K. Wan
Edmond S. K. Ma
机构：
[1] Queen Mary Hospital,Department of Medicine
[2] Queen Mary Hospital,Department of Pathology
[3] Hong Kong Sanatorium & Hospital,Department of Pathology
来源：
International Journal of Hematology | 2013年 / 97卷
关键词：
Imatinib; Tyrosine Kinase Inhibitor; Tenofovir; Chronic Myelogenous Leukemia; Imatinib Mesylate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：435 / 437
页数：2
相关论文
共 50 条
  • [1] JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion
    Au, Wing-Yan
    Wan, Thomas S. K.
    Ma, Edmond S. K.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 435 - 437
  • [2] Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2)
    Takeuchi, Mai
    Katayama, Yoshio
    Okamura, Atsuo
    Yamamoto, Katsuya
    Shimoyama, Manabu
    Matsui, Toshimitsu
    CANCER GENETICS AND CYTOGENETICS, 2007, 179 (01) : 85 - 87
  • [3] Concomitant BCR ABL Translocation and JAK2 V617F Mutation in Myeloproliferative Disorders
    Hummel, J. M.
    Sanks, J.
    Chiselite, M.
    Smith, L. B.
    Johnson, K. Elenitoba
    Lim, M. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [4] Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2)
    Bustamante, Daniel
    Chan, Kathryn R.
    Czuchlewski, David R.
    Al Saadi, A. Amir
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (03) : 324 - 326
  • [5] Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2)
    Daniel Bustamante
    Kathryn R. Chan
    David R. Czuchlewski
    A. Amir Al Saadi
    International Journal of Hematology, 2012, 95 : 324 - 326
  • [6] Secondary t(9;22)(q34;q11.2)/BCR-ABL1 Rearrangement Is a Fatal Event in Myeloid/Lymphoid Neoplasms
    Zheng, Lan
    Han, Xin
    Gong, Zimu
    Medeiros, L. Jeffrey
    Hu, Shimin
    MODERN PATHOLOGY, 2017, 30 : 388A - 388A
  • [7] Secondary t(9;22)(q34;q11.2)/BCR-ABL1 Rearrangement Is a Fatal Event in Myeloid/Lymphoid Neoplasms
    Zheng, Lan
    Han, Xin
    Gong, Zimu
    Medeiros, L. Jeffrey
    Hu, Shimin
    LABORATORY INVESTIGATION, 2017, 97 : 388A - 388A
  • [8] Rare examples of Philadelphia positive CML with concomitant BCR-ABL1 translocation and JAK2 V617F mutation
    Akiki, S.
    Rose, S.
    Bryon, J.
    Jeffries, S.
    Murray, J.
    Raghavan, M.
    Griffiths, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 77 - 77
  • [9] High performance of the BCR/ABL-extra sensitive (ES) probe for detection of der(9q) deletion in t(9;22) (q34;q11.2)
    Najfeld, V
    CANCER GENETICS AND CYTOGENETICS, 2002, 132 (02) : 171 - 171
  • [10] Novel Variant Ph Translocation t(9;22;11)(q34;q11.2;p15)inv(9)(p13q34) in Chronic Myeloid Leukemia Involving a One-Step Mechanism
    Belli, C.
    Alu, M. F.
    Alfonso, G.
    Bianchini, M.
    Larripa, I.
    CYTOGENETIC AND GENOME RESEARCH, 2011, 132 (04) : 304 - 308
12345